The Role of Ozonized Erythrocytic Mass Transfusion in the Restoration of Myocardial Morphological Changes during Blood Loss (Experimental Study)
https://doi.org/10.15360/1813-9779-2018-3-27-35
Abstract
Purpose. To evaluate the role of ozonized erythrocytic mass transfusion in the restoration of damages in the architectonics of myocardium microvasculature and cardiomyocytes in case of a severe blood loss.
Materials and Methods. Two batches of experiments were conducted, 17 white outbred rats in each. The animals were anesthetized with thiopental sodium (25 mg/kg). Blood loss was caused by taking 3ml of blood from the tail artery of rats, which is 35% of the circulating blood volume. One hour after the blood loss, transfusion of autoerythrocytes with normal saline solution and Ringer’s solution infusion in 1:1 ratio was performed in the control batch. In the experimental batch, 3 ml of autoerythrocytes treated with ozonized saline solution with ozone concentration of 2 mg/l and 3 ml of Ringer’s solution (1:1 ratio) were administered to rats. Erythrocyte mass was prepared from 3 ml of the autoblood harvested from the animals 3 days before the experiment. On a post-transfusion day5, in both batches and in five intact animals, hearts were removed following the intraperitoneal thiopental sodium injection (100 mg/kg). The left ventricle wall specimen from each heart was removed for examination. Histologic sections were stained with hematoxylin and eosin. The preparations were visually examined and morphometric studies were performed using microvisor Vizo-103.
Results. It has been established that administration of ozonized erythrocyte for severe blood loss correction limited the decrease in numbers of capillary profiles and their diameters, formation of mixed and hyaline thrombi fully or partially occluding microvascular lumens, major hemorrhages and reduction of variation of nuclear profiles, decreased perivascular, pericellular, perinuclear, and endonuclear edema of myocardial tissue, cardiomyocyte overcontruction zone, and their ruptures.
Conclusion. The positive trends for microcirculation indices, vascularization density and myocardial edematization as prognostic markers in assessing potential posthypoxic rehabilitation of damaged tissues upon blood loss correction with ozonized erythrocyte mass might be explained by the antihypoxic, antioxidant, and detoxifying actions of ozone on erythrocytes and/or its metabolites (ozonides) in the body post-transfusion.
About the Authors
G. A. BoyarinovRussian Federation
10/1 Minin and Pozharsky Sq., GSP-470, 603950 Nizhny Novgoro
I. S. Simutis
Russian Federation
10/1 Minin and Pozharsky Sq., GSP-470, 603950 Nizhny Novgoro
V. O. Nikolsky
Russian Federation
198 Rodionova Str., 603093 Nizhny Novgorod
A. V. Deryugina
Russian Federation
23 Gagarin Av., GSP-20, 603950 Nizhny Novgorod
L. V. Boyarinova
Russian Federation
10/1 Minin and Pozharsky Sq., GSP-470, 603950 Nizhny Novgoro
A. S. Gordetsov
Russian Federation
10/1 Minin and Pozharsky Sq., GSP-470, 603950 Nizhny Novgoro
A. B. Kuznetsov
Russian Federation
23 Gagarin Av., GSP-20, 603950 Nizhny Novgorod
References
1. . Moroz V.V., Ryzhkov I.A. Acute blood loss: regional blood flow and microcirculation (review, part I). Obshchaya Reanimatologiya = General Reanimatology. 2016; 12 (2): 66-89. DOI: 10.15360/1813-9779-2016-256–65. [In Russ., In Engl.]
2. Shifman E.M., Kulikov A.V., Belomestnov S.R. Intensive care and anesthesia for blood loss in obstetrics. Anesteziologiya i Reanimatologiya. 2014; 2: 76–78. PMID: 25055500. [In Russ.]
3. Moroz V.V., Ryzhkov I.A. Acute blood loss: regional blood flow and microcirculation (review, part II). Obshchaya Reanimatologiya = General Reanimatology. 2016; 12 (5): 65–94. DOI: 10.15360/1813-9779-20165-65-94. [In Russ., In Engl.]
4. Krylov V.N., Deryugina A.V., Simutis I.S., Boyarinov G.A., Senyurina A.I. Contents of ATP and 2,3-DPG in erythrocytes for preservation and ozone exposurel. Biomeditsina. 2014; 1 (2): 37–42. [In Russ.]
5. Simutis I.S., Boyarinov G.A., Mukhin A.S., Prilukov D.B., Deryugina A.V. The new possibilities for the rehabilitation of conserved erythrocytes with the use of ozone. Fizioterapiya, Balneologiya i Reabilitatsiya. 2014; 6: 8–12. [In Russ.]
6. Simutis I.S., Boyarinov G.A., Mukhin A.S., Deryugina A.V. Possibilities of pre-transfusion conditioning of packed erythrocytes with ozone. Bioradikaly i Antioksidanty. 2016; 3 (1): 63–68. [In Russ.]
7. Avtandilov G.G. Medical morphometry. Leadership. Moscow: Meditsina Publishers; 1990: 384. [In Russ.]
8. Malakhov V.A., Belous A.M., Pasyura I.N., Doroshenko G.I. Cell-metabolic aspects of pathogenesis, treatment and prevention of chronic cerebral ischemia and neurodegenerative processes. Kharkov: Ranok; 1999: 175. [In Russ.]
9. Peretyagin P.V., Martusevich A.K., Peretyagin S.P. Experimental evaluation of the microcirculation state in the systemic administration of ozonized saline. Bioradikaly i Antioksidanty. 2015; 2 (1): 54–61. [In Russ.]
10. Muñoz A. Design and analysis of studies of the health effects of ozone. Environ. Health Perspect. 1993; 101 Suppl 4: 231–235. DOI: 10.1289/ehp.93101s4231. PMID: 8206039
11. Mudd J.B., Dawson P.J., Adams J.R., Wingo J., Santrock J. Reaction of ozone with enzymes of erythrocyte membranes. Arch. Biochem. Biophys. 1996; 335 (1): 145–151. DOI: 10.1006/abbi.1996.0492. PMID: 8914845
12. Jacobs M.Т. Adverse effects and typical complications in ozone-oxygen therapy. Ozonachrichten. 1983; 1: 193–201.
13. Razumovsky S.D., Zaikov G.E. Ozone and its reactions with organic compounds. Moscow: Nauka; 1974: 312. [In Russ.]
14. Buyuklu M., Kandemir F.M., Set T., Bakirci E.M., Degirmenci H., Hamur H., Topal E., Kucukler S., Turkmen K. Beneficial effects of ozone therapy on oxidative stress, cardiac functions and clinical findings in patients with heart failure reduced ejection fraction. Cardiovasc. Toxicol. 2017; 17 (4): 426-433. DOI: 10.1007/s12012-017-9400-8. PMID: 28097518
15. Alekhina S.P., Shcherbatyuk T.G. Ozone therapy: clinical and experimental aspects. Nizhny Novgorod: Litterra; 2003: 240. [In Russ.]
16. Boyarinov G.A., Sokolov V.V. Ozonized artificial circulation (experimental substantiation and results of clinical application). Nizhny Novgorod: Pokrovka; 1999: 318. [In Russ.]
17. Rokitanscy O. Clinical considerations and biochemistry of ozone therapy. Hospitalis. 1982; 52: 643–647.
18. Boyarinov G.A., Veksler N.Yu., Boyarinova L.V., Akhmerov F.Sh., Yuryev M.Yu., Goryachev M.E. Detoxifying effect of ozone. Kazansky Meditsinsky Zhurnal. 2007; 88 (4): 261–263. [In Russ.]
19. Veksler N.Yu., Boyarinov G.A., Makarov N.A., Mukhin A.S., Germanova T.A., Chastov V.P. Correction of endotoxicosis by the oriented action on toxic agents. Rossiisky Meditsinsky Zhurnal. 2004; 3: 29–32. [In Russ.]
20. Veksler N.Yu., Boyarinov G.A., Makarov N.A., Mukhin A.S., Chastov V.P., Burovkin B.A., Smirnov N.F., Petrova L.A. Correction of endotoxicosis within the complex intensive therapy for acute destructive pancreatitis. Rossiisky Meditsinsky Zhurnal. 2004; 4: 14–17. [In Russ.]
21. Re L., Rowen R., Travagli V. Ozone therapy and its use in medicine: further comments. Cardiology. 2017; 136 (4): 269. DOI: 10.1159/000452618. PMID: 27894109.
Review
For citations:
Boyarinov G.A., Simutis I.S., Nikolsky V.O., Deryugina A.V., Boyarinova L.V., Gordetsov A.S., Kuznetsov A.B. The Role of Ozonized Erythrocytic Mass Transfusion in the Restoration of Myocardial Morphological Changes during Blood Loss (Experimental Study). General Reanimatology. 2018;14(3):27-35. https://doi.org/10.15360/1813-9779-2018-3-27-35